
Genetics Firm 23andMe Files Bankruptcy, Seeks Buyer in Missouri Court
SAN FRANCISCO — On March 23, 2025, 23andMe Holding Co. (Nasdaq: ME), a prominent genetics and biotechnology firm, announced it has voluntarily filed for Chapter 11 bankruptcy protection in the U.S. Bankruptcy Court for the Eastern District of Missouri. The …